EMD Millipore has decided to financially support research at The Breast Cancer Research Foundation® (BCRF). The company says that it will allocate a portion of product sales and a $20,000 grant as well as feature the BCRF pink logo on select products and packaging to promote breast cancer awareness.
“As many of our products are used to research and combat cancer, we felt it was important to partner with a leading organization also dedicated to this fight,” says John Sweeney, vp, life sciences.
From today through September 30, 2011, EMD Millipore will give a percentage of money received through the sale of Guava® Flow Cytometry EasyCyte™ systems to BCRF. The company will donate $300 or $800 for each instrument sold to this charity. This donation combined with the $20,000 grant is expected to support over 170 BCRF researchers.
EMD Millipore is the life science division of Merck KGaA. It was formed through Merck’s $7 billion acquisition of Millipore, which closed in July. EMD Millipore offers a range of products, services, and business relationships that enable research, development, and production of biotech and pharmaceutical drugs. Headquartered in Billerica, MA, the division has around 10,000 employees, operations in 64 countries, and had pro forma 2009 revenues of $2.9 billion.
The Breast Cancer Research Foundation was founded in 1993 by Evelyn H. Lauder as an independent, not-for-profit organization dedicated to funding innovative clinical and translational research. BCRF says that, this month, it will award $33 million to 172 scientists across Australia, Canada, Europe, Latin America, the Middle East, and the U.S. Reportedly more than 90 cents of each dollar donated to the foundation goes directly to breast cancer research and awareness programs.